Zadenvi
Analogs of Zadenvi
Find cheaper analogs and generic equivalents for Zadenvi.
Active Ingredient: denosumab
Product Overview
About Zadenvi
Zadenvi is a solution for injection in prefilled syringes.
What it is used for
Not available in the provided facts.
How it is used
Zadenvi is given once every 6 months as a 60 mg injection under the skin in the thigh, abdomen (belly) or back of the arm. During treatment with Zadenvi, the doctor should ensure that the patient is receiving calcium and vitamin D supplements. Zadenvi can be given by someone who has been trained in how to give injections appropriately.
How it works
The active substance in Zadenvi, denosumab, is a monoclonal antibody (a type of protein) that has been designed to recognise and attach to a specific structure in the body called RANKL. RANKL is involved in activating osteoclasts, the cells in the body that are involved in breaking down bone tissue. By attaching to and blocking RANKL, denosumab reduces the formation and activity of the osteoclasts. This reduces the loss of bone and maintains bone strength, making fractures less likely to happen.
Active substance: denosumab
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.
